Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/22/26 16:05 | 7/20/26 | SGMT | Health | Drug | Pharmaceutical Preparations | Happel David | CA | DO | P,CEO | 3 | S | -1,160 | 8.19 | 0 | -142 | 742 | D | |||||||||||||||
7/22/26 16:05 | 7/20/26 | SGMT | Health | Drug | Pharmaceutical Preparations | Rozek Elizabeth | CA | O | Chief Le | 3 | S | -194 | 8.12 | 0 | -24 | 224 | D | |||||||||||||||
7/22/26 16:05 | 7/20/26 | SGMT | Health | Drug | Pharmaceutical Preparations | Kemble George | CA | D | 2 | S | -431 | 7.62 | 0 | -57 | 81 | D | ||||||||||||||||
2/12/26 16:07 | 2/10/26 | SGMT | Health | Drug | Pharmaceutical Preparations | Chauche Thierry | CA | O | CFO | 1 | S | -7 | 5.36 | 0 | -1 | 16 | D | |||||||||||||||
2/12/26 16:06 | 2/10/26 | SGMT | Health | Drug | Pharmaceutical Preparations | Martins Eduardo Bruno | CA | O | Chief Me | 2 | S | -95 | 7.98 | 0 | -12 | 107 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |